COMBACTE

@IHIEurope Project on Combatting #BacterialResistance in Europe. Collaboration between academia&industry for the research & development of new drugs against AMR

[COMBACTE @COMBACTE]

Thrilled to announce a brand new publication from COMBACTE-CARE's consortium in the @TheLancetInfDis on safety and efficacy of ATM-AVI for treating serious #infections caused by Gram-negative #bacteria 🦠

👉https://t.co/BJHppT9PCL

@IHIEurope @EFPIA @pfizer

[VITAL @VITAL_Europe]

Have you registered? VITAL's final scientific symposium on #vaccination in older adults will highlight the latest research and strategies, as well as VITAL's sustainability in the future.
👉https://t.co/pe5huATeTa

@DebbieBaarle @UMCG @RIVM @Sanofi @Ecraid
#HealthyAging #Vaccines

[VITAL @VITAL_Europe]

Join us for our final scientific symposium on #vaccination in older adults and learn about the latest research and strategies, as well as VITAL's sustainability in the future.
https://t.co/rDvkspifze

@DebbieBaarle @UMCG @RIVM @GSK
#HealthyAging #Vaccines

[COMBACTE @COMBACTE]

Thrilled to announce a brand new publication from COMBACTE-CARE's consortium in the @TheLancetInfDis on safety and efficacy of ATM-AVI for treating serious #infections caused by Gram-negative #bacteria 🦠

👉https://t.co/BJHppT9PCL

@IHIEurope @EFPIA @pfizer

[COMBACTE @COMBACTE]

⏰Last chance to register for the Post-graduate course offered by @Ecraid in collaboration with @ESCMID. Enhance your skills with the help of top experts like @MarcBonten!

📝https://t.co/IZXK2bMbVz

📅 22-24 October 2024
📍 Belgrade, Serbia
⏳ Registration closes 6 October

[COMBACTE @COMBACTE]

⏰Last chance to register for the Post-graduate course offered by @Ecraid in collaboration with @ESCMID. Enhance your skills with the help of top experts like @MarcBonten!

📝https://t.co/IZXK2bMbVz

📅 22-24 October 2024
📍 Belgrade, Serbia
⏳ Registration closes 6 October

[COMBACTE @COMBACTE]

📣 Calling researchers in clinical microbiology and infectious diseases! Sharpen your skills and refine your research methodologies with this postgraduate course organised by @Ecraid and @ESCMID.
⏰ Limited spots left - register today!

[Innovative Health Initiative @IHIEurope]

📢 Read all about it! 🗞️ IHI's June newsletter is now live!➡️ https://t.co/gphl7E7Q7W Find out:
☑️ Everything you wanted to know about call 8
☑️ New #EPI solutions
☑️ Research into whether #SmartHomes can predict onset of #dementia
☑️Events to catch up on
#IHITransformingHealth

[VITAL @VITAL_Europe]

Our latest scientific paper dives into the influence of healthcare workers on older adults' #vaccine acceptance. Published in @BioMedCentral 👇 https://t.co/xDGKSodlMQ

@DebbieBaarle @RIVM @Radboud_Uni @VUamsterdam

#InfectiousDiseases #HealthyAging

[COMBACTE @COMBACTE]

Check the thread below on the latest COMBACTE-CARE publication on international and regional spread of #carbapenem-resistant #Klebsiella pneumoniae in Europe: https://t.co/pXjPcMGoCY
@IHIEurope @EUScienceInnov @Uniklinik_Fr @MedMicroLab_UA @HUVMacarena @ciberinfec @ibis_sevilla

[COMBACTE @COMBACTE]

Dive into our recent publication assessing the clinical presentation of invasive E. coli disease & #antimicrobialresistance patterns of causative E. coli isolates in older adults https://t.co/ccr6nPv8SA

@IHIEurope @JanssenUS @HUVMacarena @IenI_UMCUtrecht @MarcBonten @jesusrbano

[COMBACTE @COMBACTE]

Last week's @IHIEurope webinar featured our academic and pharmaceutical partners discussing the collaboration within the projects, and its outstanding milestones 👇

Watch now: https://t.co/SbOarNqhJB

@Ecraid @CHULimoges @Pfizer @UMCU_Intl @HorizonEU @EU_Commission @HUVMacarena

[Marc Bonten @MarcBonten]

Day2 of #UADays24 and ready to start with my lecture on the role of clinical trial networks in solving the global #AMR problem. Will address the evolution of @COMBACTE into @Ecraid @IHIEurope @EU_Commission

[COMBACTE @COMBACTE]

@CHULimoges @HUVMacarena @Pfizer @Aridis_Pharma

[COMBACTE @COMBACTE]

This Friday @IHIEurope will be hosting an impact webinar highlighting the significant outcomes of the COMBACTE projects in combating #antimicrobialresistance 🦠

The Legacy of the COMBACTE Projects: https://t.co/fy5vaeqP7e

@Ecraid @MarcBonten @jesusrbano @IenI_UMCUtrecht @EFPIA

[COMBACTE @COMBACTE]

@EJuskewitz @IHIEurope @Ecraid @MarcBonten @jesusrbano @IenI_UMCUtrecht @EFPIA Hi Eric, it should work now. Please use the registration link on this page: https://t.co/freCqIDLcb If not, let us know!

[COMBACTE @COMBACTE]

Thinking of a bit of scientific reading this weekend? Look no further! This COMBACTE-NET paper on invasive E. coli disease (IED) explores results from our EXPECT-1 observational study
👉https://t.co/oc4hhLuKV5
@IHIEurope @SpringerNature @IenI_UMCUtrecht @Ecraid @JanssenUS

[Innovative Health Initiative @IHIEurope]

💡If you're interested in the #AMR results from the @COMBACTE projects, join us on 31 May for our Impact webinar - Combatting antimicrobial restistance🦠: the legacy of the @COMBACTE projects. More info & register here: https://t.co/PuKnEYr2wy

[COMBACTE @COMBACTE]

Today we celebrate #ClinicalTrialsDay recognising groundbreaking innovations, but more importantly the clinical researchers behind them. Their efforts, dedication & curiosity leading to these breakthroughs #CTD2024
@IHIEurope @EFPIA @IenI_UMCUtrecht @Ecraid @ACRPDC @EU_Commission

[Innovative Health Initiative @IHIEurope]

Save the date - 31 May 2024 - to find how the @COMBACTE projects leveraged #PPP to combat #AntimicrobialResistance, which causes more than 35K deaths/year. Register now: https://t.co/PuKnEYquH0 #EUResearch #EUInnovation